Santé & Pharma

Foresight Acquisition Corp.

Forest Road Acquisition Corp.

Forian Inc.

67,8M

Forma Therapeutics Holdings, Inc.

Formycon AG

339M

Forte Biosciences, Inc.

1,6B

Fortress Biotech, Inc.

78M

Forza Innovations Inc

252,2k

Frans Venker

414,9M

Frans Venker

Fredun Pharma

14,8B

Fredun Pharma

24,9B

Frequency Therapeutics, Inc.

Fresenius Medical Care AG

11,1B

Fresenius SE & Co. KGaA

25,7B

Fulcrum Therapeutics, Inc.

293M

Fulgent Genetics, Inc.

585,3M

Fusion Pharmaceuticals Inc.

Future Health ESG Corp.

G1 Therapeutics, Inc.

GAROFALO HEALTH CARE

501,5M

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A. ACQUISISCE CASA DI CURA CITTA’ DI ROMA / GAROFALO HEALTH CARE S.P.A. ACQUIRES CASA DI CURA CITTA' DI ROMA

485,6M

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: ASSEMBLEA ORDINARIA E STRAORDINARIA DEGLI AZIONISTI / ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING

485,6M

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: IL CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 31 MARZO 2026 / BOARD OF DIRECTORS APPROVES INTERIM FINANCIAL REPORT AT MARCH 31, 2026

501,5M

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: STANDARD ETHICS ALZA IL RATING DI SOSTENIBILITA' / STANDARD ETHICS RAISES SUSTAINABILITY RATING

485,6M

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: STANDARD ETHICS CONFERMA IL RATING ESG DI BREVE E MEDIO/LUNGO TERMINE / STANDARD ETHICS CONFIRMS SHORT-TERM AND MEDIUM/LONG-TERM ESG RATINGS

485,6M

GAROFALO HEALTH CARE GHC ACQUISISCE LO STORICO GRUPPO ROMANO DA CUI HA TRATTO LE SUE ORIGINI / GHC ACQUIRES THE HISTORICAL ROMAN GROUP FROM WHICH IT DREW ITS ORIGINS

494,4M

GAROFALO HEALTH CARE SPA

498M

GBS Inc.

GBS Inc.

GC메디아이

155,9B

GDR

10,2M

GENFIT

661,3M

GENOMED S.A.

GENOWAY

29,6M

GERON CORP

930,2M

GLAUKOS Corp

9,1B

GMR Solutions Inc.

624M

GRAIL, Inc.

4,8B

GRIFOLS, S.A

6,5B

GRIFOLS, S.A.

6,6B

GROUPE TERA

8,5M

GSK plc

76,3B

GSS

249,6k

GT Biopharma, Inc.

10,7M

GUERBET

90,3M

GVS GVS

GVS SPA

862,3M

GW Pharmaceuticals PLC

Gabather AB

18,3M